Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Europe Lung Cancer Surgery Market - Industry Trends and Forecast to 2029
... new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. Market Segmentation Europe Lung Cancer Surgery Market, By Product Type ... Read More
-
APAC Lung Cancer Surgery Market - Industry Trends and Forecast to 2029
... The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. Market Segmentation Asia-Pacific Lung Cancer Surgery Market, By Product ... Read More
-
Uterine Cancer Therapeutics & Diagnostics
... at US$18.4 Billion in the year 2020, is projected to reach a revised size of US$24.3 Billion by 2027, growing at aCAGR of 4.1% over the period 2020-2027. Endometrial Carcinomas, one of the segments analyzed ... Read More
-
NA Hereditary Cancer Testing Market - Industry Trends and Forecast to 2029
... new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029. Market Segmentation North America Hereditary Cancer Testing Market, By Test ... Read More
-
Ovarian Cancer Market Share, Size, Trends, Industry Analysis Report, By Type (Epithelial Tumors, Germ Cell Tumors, Stromal Tumors, and Primary Peritoneal Cancer); By Diagnosis; By Therapeutic Treatment; By End-User; By Region; Segment Forecast, 2022 - 203
... 2030 The global ovarian cancer market is expected to reach USD 9.67 billion by 2030, according to a new study by Polaris Market Research. The report “Ovarian Cancer Market Share, Size, Trends, Industry Analysis Report, ... Read More
-
Pancreatic Cancer Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, and Others); By Diagnosis; By Cancer Type, By End-Users; By Region; Segment Forecast, 2022 - 2030
... global pancreatic cancer market size is expected to reach USD 7.04 million by 2030, according to a new study by Polaris Market Research. The report “Pancreatic Cancer Market Share, Size, Trends, Industry Analysis Report, By ... Read More
-
Global Lung Cancer Genomic Testing Market By Component (Products v/s Services), By Technology (Next Generation Sequencing, Polymerase Chain Reactions, Fluorescence In Situ Hybridization (FISH)/In Situ Hybridization (ISH), Others), By Panel Type (Single Panel v/s Multi-Gene Panel), By Sample Type (Tissue Biopsy v/s Liquid Biopsy), By End User (Academic & Research Institutions, Hospitals & Clinics, Diagnostic Laboratories, Others), and By Region, Competition Forecast and Opportunities, 2027
... Panel), By Sample Type (Tissue Biopsy v/s Liquid Biopsy), By End User (Academic & Research Institutions, Hospitals & Clinics, Diagnostic Laboratories, Others), and By Region, Competition Forecast and Opportunities, 2027 The global lung cancer genomic ... Read More
-
NA Lung Cancer Surgery Market - Industry Trends and Forecast to 2029
... The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. Market Segmentation North America Lung Cancer Surgery Market, By ... Read More
-
Cancer Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Cancer Pain (Central Nervous System) pipeline landscape. Cancer pain can be defined as a complex sensation that reflects both damage to the body and the body's response to the damage. ... Read More
-
Global Multi Cancer Early Detection Market Size study, By Type (Liquid Biopsy, Gene Panel, LDT, & Others), By End-User (Hospitals, Diagnostic Laboratories, Others), and Regional Forecasts 2022-2028
... at approximately USD 791.58 million in 2021 and is anticipated to grow with a healthy growth rate of more than 15.0% over the forecast period 2022-2028. Multi-cancer detection (MCD) measure biological signals that may be ... Read More
-
Global Undifferentiated Pleomorphic Sarcoma Therapeutics Market - 2022-2029
... at a CAGR of XX % during the forecast period (2022-2029). Soft tissue cancers include malignant fibrous histiocytoma, often undifferentiated pleomorphic sarcoma. It's rare cancer that frequently metastasizes to other body regions and returns after ... Read More
-
Global Cutaneous Squamous Cell Carcinoma Market - 2022-2029
... a CAGR of 7.2 % during the forecast period (2022-2029). Cancer starts in the cells that make up the epidermis (the outer layer of the skin). It commonly develops in parts of the skin that ... Read More
-
Global Wearable Injectors Market Size study, By Type (On-body, Off-body), By Technology (Spring-based, Motor-driven, Rotary Pump, Expanding Battery, Other), By Application (Oncology, Infectious Disease, Cardiovascular Disease, Autoimmune Disease, Other), By End User (Hospital, Clinic, Home Care, Other), and Regional Forecasts 2022-2028
... Care, Other), and Regional Forecasts 2022-2028 Global Wearable Injectors Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast ... Read More
-
Global Artificial Intelligence (AI) in Oncology Market Size study, by Treatment (Hemotherapy, Radiotherapy, Immunotherapy, Targeted Therapy, Gene Therapy, And Others) by Type (Lung Cancer, Breast Cancer, Melanoma Cancer, Prostate Cancer, Colorectal Cancer, Among Others), by Application (Diagnosis, Therapy, Prognosis, Health Management, Research) and Regional Forecasts 2022-2028
... Application (Diagnosis, Therapy, Prognosis, Health Management, Research) and Regional Forecasts 2022-2028 Global Artificial Intelligence (AI) in Oncology Market is valued at approximately USD XX Million in 2021 and is anticipated to grow with a healthy ... Read More
-
Custom Antibody Service Market, by Service Type (Antibody Development, Antibody Production, Downstream Antibody Services, Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)), by Product Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), by Source (Rabbit, Chicken, Guinea pig, Goat, Mouse, Others (Rat and Others)), by Application (Oncology, Infectious diseases, Immunology, Neurobiology, Stem cells, Other (Cardiovascular Disease and Others)), by End Users (Pharmaceutical & biotechnology companies, Academic & research institutes, Contract research organizations), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... (Rabbit, Chicken, Guinea pig, Goat, Mouse, Others (Rat and Others)), by Application (Oncology, Infectious diseases, Immunology, Neurobiology, Stem cells, Other (Cardiovascular Disease and Others)), by End Users (Pharmaceutical & biotechnology companies, Academic & research institutes, ... Read More
-
Asia-Pacific Colorectal Cancer Market to 2028 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country
... is expected to grow from US$ 3,864.66 million in 2022 to US$ 5,169.04 million by 2028; it is estimated to grow at a CAGR of 3.7% from 2022 to 2028. The growing pharmaceutical industry in ... Read More
-
2022 Czech Republic Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline
... Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and ... Read More
-
2022 Panama Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline
... Forecasts through 2026, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ... Read More
-
2022 Morocco Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline
... Forecasts through 2026, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ... Read More
-
2022 Belgium Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline
... Forecasts through 2026, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ... Read More
-
2022 Nicaragua Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline
... Forecasts through 2026, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ... Read More
-
2022 Poland Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline
... Forecasts through 2026, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ... Read More
-
2022 Lithuania Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline
... Forecasts through 2026, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ... Read More
-
2022 Netherlands Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline
... Forecasts through 2026, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ... Read More
-
2022 New Zealand Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline
... Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and ... Read More
Research Assistance
